All Updates

All Updates

icon
Filter
M&A
Sidekick Health acquires PINK! to expand into oncology and women's health
Preventive Healthcare
Jun 18, 2024
This week:
Partnerships
MGI Tech and Predica Diagnostics collaborate to develop Predica's targeted RNA sequencing tests
Precision Medicine
Yesterday
Partnerships
Renalytix partners with Steno Diabetes Center to advance precision medicine solutions for diabetes and chronic kidney disease
Precision Medicine
Yesterday
Partnerships
Myriad Genetics and Personalis cross-license patents for tumor-informed cancer treatment tests
Precision Medicine
Yesterday
Funding
Element Biosciences raises USD 277 million in Series D funding to commercialize AVITI DNA sequencer and support AVITI24 launch
Precision Medicine
Yesterday
Funding
Jacobi Robotics raises USD 5 million in seed funding to expand capacity
Smart Factory
Yesterday
M&A
Formlabs acquires Micronics for undisclosed sum to develop next-generation SLS printers
Additive Manufacturing
Yesterday
Partnerships
Anthropic partners with Amazon Bedrock to fine-tune Claude 3 Haiku model
Foundation Models
Yesterday
Funding
Lemon.markets raises EUR 12 million in funding to support growth
FinTech Infrastructure
Yesterday
M&A
Kipu Quantum acquires PlanQK platform to enhance accessibility to quantum computing solutions
Quantum Computing
Yesterday
Partnerships
Quantinuum and STFC Hartree Centre partner to enhance quantum computing accessibility in UK
Quantum Computing
Yesterday
Preventive Healthcare

Preventive Healthcare

Jun 18, 2024

Sidekick Health acquires PINK! to expand into oncology and women's health

M&A

  • Digital Therapeutics (DTx) company Sidekick Health has acquired PINK!, a digital health company specializing in cancer support and women's health, for an undisclosed sum.

  • The acquisition will allow Sidekick Health to integrate PINK!'s breast cancer digital therapeutic, PINK! Coach, into its portfolio. This will enable the company to offer a range of digital therapeutics to patients, including further expansion within women's health and oncology in the US and EU. Further, PINK!'s team will join Sidekick Health after the acquisition. 

  • Germany-based PINK! developed PINK! Coach as the first and only prescription digital therapeutic for breast cancer. It supports patients with information and daily goals in areas like exercise, diet, and mental health. The aim is to help patients manage side effects and enhance their overall quality of life during treatments.

  • Analyst QuickTake: This marks Sidekick Health’s second acquisition after acquiring aidhere, a German-based company known for its weight management app, "Zanadio," in October 2023 . This step underscores Sidekick's commitment to expanding its digital therapy options and geographical reach.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.